Delcath CHEMOSAT therapy included in European uveal melanoma guidelines
Go back to Delcath CHEMOSAT therapy included in European uveal melanoma guidelines| DELCATH SYSTEMS (NASDAQ: DCTH) | Delayed: 13.48 +0.28 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.20 | 52 Week High | $4.72 | |||
| Open | $13.25 | 52 Week Low | $0.22 | |||
| Day High | $13.74 | P/E | N/A | |||
| Day Low | $13.05 | EPS | $-102.40 | |||
| Volume | 481,220 | |||||

